Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 6,880.00
+40.00 (0.58%)
Aug 12, 2026, 2:40 PM KST
-53.10% (1Y)
| Market Cap | 82.21B -53.4% |
| Revenue (ttm) | 16.21B +87.1% |
| Net Income | -57.32B |
| EPS | -953.45 |
| Shares Out | 12.02M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 42,048 |
| Open | 6,900.00 |
| Previous Close | 6,840.00 |
| Day's Range | 6,530.00 - 6,950.00 |
| 52-Week Range | 4,945.00 - 15,900.00 |
| Beta | 0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 18, 2026 |